EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combination therapy with methylprednisolone and rivaroxaban for mild COVID-19 in Vietnam: laboratory and clinical insights

Le Thi Anh Thu, Phong Hoang, Tuan Nguyen, Nguyen Phan Hoang, Ngan La Thi Thanh, Thanh Nguyen Thi Hai, Hiep Nguyen Van, Thanh Pham Tuan, Lan Tran Thi Tuyet, Nuong Nguyen Thi My, Truc Lai Thi Thu, Toan Vi Van und 2 weitere

GMS Hygiene and Infection Control · 09.07.2025 · 20 (Doc38) · Doc38

DOI: 10.3205/dgkh000567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 09.07.2025. Verfasst von Le Thi Anh Thu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hoan My Academy, Ho Chi Minh City, Vietnam. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the efficacy and safety of methylprednisolone combined with rivaroxaban versus rivaroxaban monotherapy in mild cases of COVID-19.

Methods

This quasi-experimental study was conducted at three hospitals in Ho Chi Minh City, Vietnam, from September 2021 to March 2022. Patients received either rivaroxaban 10 mg/day (Regimen 1) or methylprednisolone 16 mg/day plus rivaroxaban 10 mg/day (Regimen 2) for 7 days. Outcomes included progression to severe disease, adverse events, and changes in clinical and laboratory parameters. Statistical analysis employed Fisher’s exact test and Generalized Estimating Equations (GEE).

Results

Among 108 patients, no progression to severe disease or deaths occurred. Regimen 2 significantly improved laboratory markers, including white blood cell counts (+0.290; p

Schlagwörter

Stichwörter der Autor:innen

COVID-19MethylprednisoloneRivaroxabancombination therapymild disease

Autor:innen und Institutionen

  • Hoan My Academy, Ho Chi Minh City, Vietnam.
  • Hoan My Thu Duc Hospital, Ho Chi Minh City, Vietnam.
  • Van Phuc 2 Hospital, Binh Duong, Vietnam.
  • University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Zitieren

APA

Thu, L. T. A., Hoang, P., Nguyen, T., Hoang, N. P., Thanh, N. T., Hai, T. N. T., Van, H. N., Tuan, T. P., Tuyet, L. T. T., My, N. N. T., Thu, T. L. T., Van, T. V., Thi, P. N., & Thien, M. N. (2025). Combination therapy with methylprednisolone and rivaroxaban for mild COVID-19 in Vietnam: laboratory and clinical insights. GMS Hygiene and Infection Control, 20(Doc38), Doc38. https://doi.org/10.3205/dgkh000567

Vancouver

Thu LTA, Hoang P, Nguyen T, Hoang NP, Thanh NT, Hai TNT, et al. Combination therapy with methylprednisolone and rivaroxaban for mild COVID-19 in Vietnam: laboratory and clinical insights. GMS Hygiene and Infection Control. 2025;20(Doc38):Doc38. doi:10.3205/dgkh000567

BibTeX
@article{Thu2025,
  author = {Thu, Le Thi Anh and Hoang, Phong and Nguyen, Tuan and Hoang, Nguyen Phan and Thanh, Ngan La Thi and Hai, Thanh Nguyen Thi and Van, Hiep Nguyen and Tuan, Thanh Pham and Tuyet, Lan Tran Thi and My, Nuong Nguyen Thi and Thu, Truc Lai Thi and Van, Toan Vi and Thi, Phuong Nguyen and Thien, Minh Nguyen},
  title = {Combination therapy with methylprednisolone and rivaroxaban for mild COVID-19 in Vietnam: laboratory and clinical insights},
  journal = {GMS Hygiene and Infection Control},
  year = {2025},
  volume = {20},
  number = {Doc38},
  pages = {Doc38},
  doi = {10.3205/dgkh000567}
}
Kostenlos starten →